Aralez Pharm Inc (ARLZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,978 | -71,862 | -51,263 | -33,788 | -37,783 |
| Depreciation Amortization | 13,052 | 6,078 | 3,518 | 1,326 | 16 |
| Income taxes - deferred | -3,952 | -1,261 | -797 | -305 | N/A |
| Accounts receivable | -7,694 | 2,135 | 2,871 | -879 | -337 |
| Other Working Capital | -2,192 | -6,256 | -10,950 | -7,721 | 13,736 |
| Other Operating Activity | 20,033 | 2,502 | -1,103 | 54 | 7,579 |
| Operating Cash Flow | $-83,731 | $-68,664 | $-57,724 | $-41,313 | $-16,789 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,166 | -2,014 | -658 | -399 | -240 |
| Net Acquisitions | -217,887 | -42,887 | -17,887 | -17,887 | N/A |
| Other Investing Activity | -715 | -801 | -593 | 0 | 2,479 |
| Investing Cash Flow | $-222,768 | $-45,702 | $-19,138 | $-18,286 | $2,239 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 275,000 | 75,000 | 75,000 | 75,000 | N/A |
| Debt Repayment | -4,700 | -4,595 | -4,595 | -673 | N/A |
| Common Stock Issued | 77,658 | 76,998 | 76,163 | 75,000 | 1,735 |
| Other Financing Activity | -1,695 | -1,660 | -1,656 | -700 | -2,951 |
| Financing Cash Flow | $346,263 | $145,743 | $144,912 | $148,627 | $-1,216 |
| Exchange Rate Effect | 363 | 340 | 166 | 182 | N/A |
| Beginning Cash Position | 24,816 | 24,816 | 24,816 | 24,816 | 40,582 |
| End Cash Position | 64,943 | 56,533 | 93,032 | 114,026 | 24,816 |
| Net Cash Flow | $40,127 | $31,717 | $68,216 | $89,210 | $-15,766 |
| Free Cash Flow | |||||
| Operating Cash Flow | -83,731 | -68,664 | -57,724 | -41,313 | -16,789 |
| Capital Expenditure | -4,166 | -2,014 | -658 | -399 | -240 |
| Free Cash Flow | -87,897 | -70,678 | -58,382 | -41,712 | -17,029 |